Evidence map›Paper›PMID 27299649›Full record

ArticleNanoscale research letters2016

Preparation of HCPT-Loaded Nanoneedles with Pointed Ends for Highly Efficient Cancer Chemotherapy.

Shichao Wu, Xiangrui Yang, Yang Li, Hongjie Wu, Yu Huang, Liya Xie, Ying Zhang, Zhenqing Hou, Xiangyang Liu

Abstract read
In one paragraph

Article in Nanoscale research letters, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Shichao WuInstitute of Soft Matter and Biomimetics, College of Materials, Xiamen University, Xiamen, 361005, China.
Xiangrui YangInstitute of Soft Matter and Biomimetics, College of Materials, Xiamen University, Xiamen, 361005, China.
Yang LiInstitute of Soft Matter and Biomimetics, College of Materials, Xiamen University, Xiamen, 361005, China.
Hongjie WuSchool of Pharmaceutical Sciences, Xiamen University, Xiamen, 361005, China.
Yu HuangInstitute of Soft Matter and Biomimetics, College of Materials, Xiamen University, Xiamen, 361005, China.
Liya XieThe First Affiliated Hospital of Xiamen University, Xiamen, 361002, China. xly885@163.com.
Ying ZhangDepartment of Radiology, Taishan Medical University, Tai'an, China.
Zhenqing HouInstitute of Soft Matter and Biomimetics, College of Materials, Xiamen University, Xiamen, 361005, China. houzhenqing@xmu.edu.cn.
Xiangyang LiuInstitute of Soft Matter and Biomimetics, College of Materials, Xiamen University, Xiamen, 361005, China. Liuxy@xmu.edu.cn.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The high-aspect-ratio nanoparticles were proved to be internalized much more rapidly and efficiently by cancer cells than the nanoparticles with an equal aspect ratio. Herein, a kind of high-aspect ratio, pointed-end nanoneedles (NDs) with a high drug loading (15.04 %) and the prolonged drug release profile were fabricated with an anti-tumor drug-10-hydroxycamptothecin (HCPT)-via an ultrasound-assisted emulsion crystallization technique. It is surprising to see that the cellular internalization of NDs with an average length of 5 μm and an aspect ratio of about 12:1 was even much faster and higher than that of nanorods with the same size and the nanospheres with a much smaller size of 150 nm. The results further validated that cellular internalization of the nanoparticles exhibited a strong shape-dependent effect, and cellular uptake may favor the particles with sharp ends as well as a high-aspect ratio instead of particle size. The NDs with enhanced cytotoxicity would lead to a promising sustained local drug delivery system for highly efficient anticancer therapy. More importantly, the fabrication of NDs opens a door to design new formulations of nanoneedle drug delivery systems for highly efficient cancer.

Indexed as

Cellular uptakeHCPTHigh-aspect ratioPointed-end

Identifiers

PMID27299649
PMCPMC4907965

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.